29 reports

First Choice (First Line Treatment) Alternative Treatment Maintenance Therapy Mild Moderate Severe ##) SYSTEMATIC THERAPY ##. ## Acne Treatment Systematic therapy refers to Acne medication that is taken by mouth.

  • Acne Treatment
  • Dermatological Condition
  • Therapy
  • Actavis plc
  • Allergan plc

Combination therapy involves use of more than one medication or drug to treat a disease.

  • Ophthalmology
  • Therapy
  • Forecast
  • Actavis plc
  • Allergan plc

The ACHIEVE II study included ##, ## U. S. adult patients randomized (##:##:##) to placebo, ubrogepant ## mg and ## mg respectively, to treat a single migraine attack of moderate-to-severe headache intensity.

  • Body Care
  • Skin Care
  • Therapy
  • World
  • Actavis plc

Pfizer has one therapy in Discovery, two in Preclinical, two in Phase I and one in Phase II.

  • Addiction Disorder
  • Therapy
  • Market Size
  • Actavis plc
  • Allergan plc
  • Financial Analysis

It is one of the leading and fasting growing companies.

  • Pharmaceutical
  • Therapy
  • Actavis plc
  • Allergan plc
  • Apotex Inc.
  • 4.8 Zytiga (abiraterone)
  • 4.1 Sensipar/Mimpara (cinacalcet)

This can potentially be done in other developing countries (like China) where affordability is one of the main factors for low treatment.

  • Generic Drug
  • Therapy
  • Actavis plc
  • Mylan Inc.
  • Sandoz Inc.

SALES OF KEYTRUDA, AN ANTI-PD-## THERAPY, WERE $##. ## BILLION IN 2016, $##M IN 2015 AND $##M IN 2014.

  • Pharmaceutical
  • Therapy
  • Actavis plc
  • AstraZeneca PLC
  • Pfizer Inc.
  • MARKET SHARE ANALYSIS 2014
  • Vendor landscape

You can easily book an appointment with one online.

  • Anti-Infective
  • Therapy
  • Actavis plc
  • Allergan plc
  • Bayer AG
  • Financial Analysis

The company has five research centers in France and one in Hungary.

  • Pharmaceutical
  • Therapy
  • Forecast
  • Actavis plc
  • Allergan plc
  • CORPORATE ANALYSIS
  • SWOT ANALYSIS

MAJOR TRENDS ##.

  • Generic Drug
  • Pharmaceutical
  • Therapy
  • Actavis plc
  • Mylan Inc.
  • Financial Analysis

In March 2016, the company launched Vraylar (cariprazine), a once-daily oral atypical antipsychotic, which was approved by the US FDA in September 2015 for the treatment of bipolar I disorder and schizophrenia in adults.

  • Pharmaceutical
  • Therapy
  • Actavis plc
  • Allergan plc
  • Mylan Inc.
  • 08. Market Landscape
  • 2014: $1,896.34 million 2019: $1,972.38 million

Drivers and Their Impact Impact on Key Customer Category Driver Unmet Medical Needs Expected Launch of New Therapies Increasing Patient Population Low Low ## ## ## ## ## High High Hospitals Low High ## ## ## ## ## ## ## ## ## ## Low Low ## ## ## ## ## High ## ## ## ## ##

  • Chronic Pain
  • Therapy
  • World
  • Forecast
  • Actavis plc
  • Vendor landscape
  • MARKET SHARE ANALYSIS 2014

You can easily book an appointment with one online.

  • Anti-Infective
  • Therapy
  • Actavis plc
  • Allergan plc
  • Merck & Co., Inc.
  • Financial Analysis

In March 2016, the company launched Vraylar (cariprazine), a once-daily oral atypical antipsychotic, which was approved by the US FDA in September 2015 for the treatment of bipolar I disorder and schizophrenia in adults.

  • Pharmaceutical
  • Therapy
  • Forecast
  • Market Size
  • Actavis plc

In March 2016, the company launched Vraylar (cariprazine), a once-daily oral atypical antipsychotic, which was approved by the US FDA in September 2015 for the treatment of bipolar I disorder and schizophrenia in adults.

  • Pharmaceutical
  • Therapy
  • Forecast
  • Market Size
  • Actavis plc
  • 19. Vendor Landscape
  • 11. Pipeline Portfolio

Cognitive behavioral therapy is one of the most popular therapies used in the treatment of depression.

  • Antidepressant
  • Therapy
  • Forecast
  • Actavis plc
  • Bristol-Myers Squibb Company
  • Financial Analysis

In March 2016, the company launched Vraylar (cariprazine), a once-daily oral atypical antipsychotic, which was approved by the US FDA in September 2015 for the treatment of bipolar I disorder and schizophrenia in adults.

  • Pharmaceutical
  • Therapy
  • Forecast
  • Market Size
  • Actavis plc

It is one of the leading and fasting growing companies.

  • Pharmaceutical
  • Therapy
  • Forecast
  • Market Size
  • Actavis plc
  • Vendor landscape
  • Market trends

You can easily book an appointment with one online.

  • Therapy
  • United States
  • World
  • Market Segment
  • Actavis plc
  • CLINICAL AND COMMERCIAL ATTRACTIVENESS

The Lancet, ##(##), ##-## < DOI> ##. ##/ S##-##(##)##- ##< / DOI>.

  • Therapy
  • Japan
  • North America
  • United States
  • Actavis plc
  • 7.2.2New Product Launches and Approvals
  • List of Tables

Augmentin is one of the most commonly prescribed primary antibiotics today.

  • Anti-Infective
  • Therapy
  • Actavis plc
  • Merck & Co., Inc.
  • The Medicines Company
  • EXALGO
  • CONTENTS

MAJOR AIMS OF THE TREATMENT OF CLINICAL PAIN ##.

  • Analgesic
  • Marijuana
  • Opioid
  • Therapy
  • Actavis plc
  • 17.1 COMPETITIVE SCENARIO

Cognitive behavioral therapy is one of the most popular therapies used in the treatment of depression.

  • Antidepressant
  • Depression
  • Therapy
  • Forecast
  • Actavis plc
  • 21.1 Competitive Scenario
  • VENDOR RANKING 2014

Drivers and Their Impact Impact on Key Customer Category High Incidence of Eye Diseases Increased Prevalence of Chronic Diseases High Unmet Medical Needs ## ## ## ## ## Hospitals Low Low ## ## ## ## ## High High Low Low ## ## ## ## ## High High Improved Diagnosis Promising Drug Pipeline

  • Eye Disease
  • Ophthalmology
  • Therapy
  • Market Size
  • Actavis plc
  • 20.1 COMPETITIVE SCENARIO
  • 20.2 MARKET SHARE ANALYSIS 2014

Drivers and their Impact Increase in Disorders Associated with CKD Increase in Aging Population Unmet Needs and SideEffects Low Low ## ## ## ## ## High High Low High ## ## ## ## ## ## ## ## ## ## Low Pharmaceutical Stores High ## ## ## ## ## Low Low ## ## ## ## ## High High

  • Therapy
  • Actavis plc
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.
  • Sanofi S.A.
  • 21.2 Market Share Analysis 2014
  • 10.1 Biologics

Drivers and their Impact Customer Category 2014 Drivers and their Impact on Cystic Fibrosis Market in Europe by Key Driver Unmet Medical Needs Increased Prevalence of Cystic Fibrosis Patient Assistance Programs Presence of Diagnostic Procedures ## ## ## ## ## Low Low ## ## ## ## ## Low Low

  • Cystic Fibrosis
  • Therapy
  • Actavis plc
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • 7. Competitive Landscape

Five companies produced oral contraceptives, one injectable and one both orals and injectable.

  • Contraceptive
  • Therapy
  • World
  • Actavis plc
  • Bayer AG
  • PRIVATE EQUITY & OWNERSHIP

Pharmaceuticals and Healthcare--> Therapy Area-- > Cardiovascular and Diabetes Pharmaceuticals and Healthcare--> Therapy Area--> Central Nervous System Pharmaceuticals and Healthcare--> Therapy Area-- > Immunology and Inflammation--> Gastroenterology Pharmace

  • Therapy
  • United States
  • Company
  • M&A
  • Actavis plc

Pharmaceuticals and Healthcare--> Therapy Area--> Oncology Pharmaceuticals and Healthcare--> Therapy Area-- Partner ##: Amgen, Inc.

  • Pharmaceutical
  • Therapy
  • United States
  • M&A
  • Actavis plc